Logo image
Muscle-Eye-Brain Disease
Journal article   Open access   Peer reviewed

Muscle-Eye-Brain Disease

Anant M Shenoy, Jennifer A Markowitz, Carsten G Bonnemann, Kalpathy Krishnamoorthy, Aaron D Bossler and Brian S Tseng
Journal of clinical neuromuscular disease, Vol.11(3), pp.124-126
03/2010
DOI: 10.1097/CND.0b013e3181c5054d
PMCID: PMC2925645
PMID: 20215985
url
https://www.ncbi.nlm.nih.gov/pmc/articles/2925645View
Open Access

Abstract

A term female infant was evaluated for global developmental delay, hypotonia, hyporeflexia, diffuse weakness including facial muscles, and visual impairment with optic nerve hypoplasia. In the absence of family history or perinatal concerns, an extensive investigation was performed, including lab studies, muscle biopsy, brain MRI and focused genetic testing. This revealed elevated serum CK, a structurally abnormal brain, and a dystrophic-appearing muscle biopsy with evidence of a glycosylation defect in the alpha-dystroglycan complex. Of the 6 known related genes, testing of the POMGnT1 gene showed three heterozygous missense mutations. Thus her history, examination, biopsy specimen, imaging, laboratory, and genetic studies are all consistent with the diagnosis of Muscle-Eye-Brain (MEB) disease. MEB is one of an emerging spectrum of congenital disorders that involve both central and peripheral nervous systems, described further in this case report.
POMT2 FKRP dystroglycanopathy congenital brain malformations fukuyama muscular dystrophy POMT1 muscle biopsy congenital muscular dystrophy POMGnT1 Fukutin syndrome LARGE Walker Warburg Muscle-Eye-Brain disease

Details

Logo image